PathAI Composite PD-L1 and AI-powered CD8+ Topology Biomarker May Improve Prediction of Immuno-Oncology Treatment Response in Patients with Melanoma at the Society for Immunotherapy of Cancer Meeting 2021
BOSTON, Nov. 12, 2021 /PRNewswire/ -- PathAI, a global provider of AI-powered technology applied to pathology announced that results from...